Lactam compound to inhibit betaamyloid peptide release or synthesis

Details for Australian Patent Application No. 2002243192 (hide)

Owner Eli Lilly and Company Elan Pharmaceuticals, Inc

Inventors Nissen, Jeffrey Scott; Thorsett, Eugene D.; John, Varghese; Audia, James Edmund; Mcdaniel, Stacey Leigh; Tung, Jay S.; Latimer, Lee H.

Agent Spruson & Ferguson

Pub. Number AU-B-2002243192

PCT Pub. Number WO02/47671

Priority 60/249,552 17.11.00 US

Filing date 5 November 2001

Wipo publication date 24 June 2002

Acceptance publication date 20 July 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

20 July 2006 Application Accepted

  Published as AU-B-2002243192

16 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002243193-Methods and compositions involving polar monomers and multivalent cations

2002243191-A SECURITY APPARATUS FOR USE IN A FIREARM